作为强大的ClpP蛋白酶激活剂,ONC201衍生的四二烯二烯二烯二烯基作为强大的ClpP蛋白酶激活剂,以应对扩散中线质瘤
Morena Miciaccia1, Olga Maria Baldelli1, Cosimo G Fortuna2
1Research Laboratory for Woman and Child Health, Department of Pharmacy─Pharmaceutical Sciences, University of Bari Aldo Moro, 70125 Bari, Italy.
Journal of medicinal chemistry
|February 20, 2025
概括
研究人员开发了新的化合物来激活人类线粒体蛋白酶hClpP,这是扩散中线质瘤的点. 化合物36 (THX6) 显示出强大的hClpP激活,并通过破坏线粒体功能来杀死DIPG细胞.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 扩散内在庞丁质瘤 (DIPG) 是一种具有有限治疗选择的侵袭性儿科脑瘤.
- 人类线粒体蛋白酶hClpP是DIPG的潜在治疗标.
- 开发新的hClpP激活剂对于推进DIPG治疗策略至关重要.
研究的目的:
- 合成和评估新系列的四二二二基 (THPPDs) 作为hClpP的激活剂.
- 确定具有显著细胞毒性对DIPG细胞的强有力的hClpP激活剂,包括对现有疗法的耐药细胞.
- 阐明DIPG细胞中已识别的化合物的作用机制.
主要方法:
- 合成了两种新型系列的四基二二胺基 (THPPDs).
- 在DIPG细胞系中测试hClpP激活和细胞毒性.
- 分析与线粒体功能相关的脂肪酸概况和蛋白质水平 (氧化酸化,生物发生,线粒体衰变).
主要成果:
- 化合物36 (THX6) 显示出强烈的hClpP激活 (EC50 = 1.18 μM).
- 化合物36在抗ONC201的DIPG细胞中表现出显著的细胞毒性 (IC50 = 0.13μM).
- 用36种改变脂肪酸水平和调节失调的线粒体蛋白进行治疗,导致线粒体功能障碍.
结论:
- 化合物36 (THX6) 是一个有前途的hClpP激活剂,对DIPG细胞具有强大的抗瘤活性.
- 36的抗瘤作用是由线粒体完整性和功能的破坏介导的.
- 这些发现表明THPPD是DIPG的潜在治疗策略.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


